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Case Report 
Long-term Survivor of Primary Anorectal Malignant
Melanoma by a Multi-disciplinary Approach
Toshihiro Yamashita,1 Hidetaka Uramoto2 and Takashi Nagaie,1 1Department of Surgery, Aso Iizuka Hospital,
Iizuka and 2Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu,
Japan.
Anorectal malignant melanoma tends to show an aggressive biological behaviour. Therefore, the 5-year
survival rate is limited. We herein present a successful case of a super-long-term survivor (20 years) who
underwent multi-disciplinary treatment. The present case suggests that a multi-disciplinary approach
may be beneficial for patients with thick and extensively sized lesions after radical resection for primary
anorectal malignant melanoma. [Asian J Surg 2011;34(2):97–98]
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Introduction
Anorectal malignant melanoma is very rare,1 and surgery
is the mainstay of treatment because there is no effective
systemic therapy.2,3 Therefore, the 5-year survival rate is
10% or less even when radical surgery is performed.4 There
are few reported cases of long-term survival. We herein
report the successful treatment of a patient by a multi-
disciplinary approach that involved surgical resection,
mitomycin C, and interferon (IFN)-beta.
Case report
A 69-year-old female was admitted to our department for
anal bleeding. A physical examination revealed no re-
markable findings in the chest or abdomen and no lym-
phadenopathy in the inguinal region. There was also no
pigmentation of the skin. A digital examination revealed
a soft, elastic mass in the anorectal region. 
Colonoscopy revealed a 5 cm × 5 cm villous, elastic,
soft, mobile, intra-luminal mass in the anal canal, located
3 cm from the anal verge. Chest X-ray, abdominal ultra-
sonography, and computed tomography of the chest and
abdomen demonstrated no distant lesions. The patholog-
ical diagnosis of the tumour was malignant melanoma.
The serum carcinoembryonic antigen and α-faetoprotein
levels were normal. The patient underwent a segmental
resection with pelvic node dissection of the lymph nodes
around the nervus obturatorius in the pelvic space; the
lymphatic flow of malignant cells was taken into careful
consideration. She suffered no major post-operative 
complications.
A histological examination revealed a blockish 50 mm ×
50 mm tumour on the dental line, approximately 6 cm
from the proximal margin of the resection because pre-
operatively, the depth of this lesion was judged to be sub-
mucosal. Microscopy revealed malignant cells with bizarre
and hyper-chromatic nuclei localised within the upper
dermal infiltration (Figure 1A). Immunohistochemically,
most of the tumour cells were positive for HMB-45
(Figure 1B), S100, and vimentin, but negative for EMA,
AE-1, AE-3, CD56, chromogranin-A, and LCA. These
findings indicated a diagnosis of primary anorectal malig-
nant melanoma. No lymph node metastasis (n = 20) was
observed. The depth of this lesion was judged to be
mucosal and was diagnosed as pathological stage 0.
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As adjuvant chemotherapy, the patient was given
20 mg mitomycin C (MMC) on the 1st postoperative day
and 3 million units of IFN-beta for 1 month following
surgery. No adverse events occurred with the exception of
a transient high fever. She was discharged after an unevent-
ful recovery on the 16th day after surgery and was sched-
uled for follow-up at regular intervals every 3 months for
the 1st year and every 6 months after that. There has been
no evidence of recurrence or metastases in the 20 years
following the operation.
Discussion
Radical resection should be the first consideration in
patients with localised anorectal malignant melanoma,
particularly those with no evidence of nodal metastasis.3
However, the 5-year survival rate is limited.4 Few cases of
long-term survival have been reported.5,6 Is additional treat-
ment necessary for this patient? To determine the prog-
nosis, we should consider two factors: tumour thickness
and size. A thin (< 1 mm)7 and small (< 25 mm)2 malignant
melanoma has a more favourable prognosis than a thicker,
larger one. The thickness and size of the lesion was 2.5 and
50 mm, respectively, in this case. Therefore, we believed
that a multi-modal approach would be needed to cure this
disease. Successful prolongation of survival has been re-
ported with the administration of IFN-beta8 and MMC.9
Consequently, she was treated with IFN-beta and MMC.
In conclusion, a multi-disciplinary approach should be
considered to cure thick and extensively sized malignant
melanomas.
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Figure 1. (A) Haematoxylin-eosin staining shows the infiltration of melanoma cells within the upper dermal layer. (B) Immunohisto-
chemical examination using HMB-45 revealed positive staining of the melanoma cytoplasm and negative staining of other tissue.
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